Compare · CLOV vs DGX
CLOV vs DGX
Side-by-side comparison of Clover Health Investments Corp. (CLOV) and Quest Diagnostics Incorporated (DGX): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CLOV and DGX operate in Medical Specialities (Health Care), so they compete in similar markets.
- DGX is the larger of the two at $21.33B, about 15.0x CLOV ($1.42B).
- Over the past year, CLOV is down 18.7% and DGX is up 8.2% - DGX leads by 27.0 points.
- DGX has been more active in the news (16 items in the past 4 weeks vs 15 for CLOV).
- DGX has more recent analyst coverage (25 ratings vs 12 for CLOV).
- Company
- Clover Health Investments Corp.
- Quest Diagnostics Incorporated
- Price
- $2.71-1.45%
- $192.67-0.94%
- Market cap
- $1.42B
- $21.33B
- 1M return
- +58.48%
- -2.57%
- 1Y return
- -18.74%
- +8.24%
- Industry
- Medical Specialities
- Medical Specialities
- Exchange
- NASDAQ
- NYSE
- IPO
- News (4w)
- 15
- 16
- Recent ratings
- 12
- 25
Clover Health Investments Corp.
Clover Health Investments, Corp. operates as a Medicare Advantage insurer in the United States. The company through its software platform provides preferred provider organization and health maintenance organization health plans for Medicare-eligible consumers. Clover Health Investments, Corp. was founded in 2014 and is headquartered in Franklin, Tennessee.
Quest Diagnostics Incorporated
Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to patients, clinicians, hospitals, independent delivery networks, health plans, employers, direct contract entities, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile paramedics, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians robust information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.
Latest CLOV
- SEC Form DEFA14A filed by Clover Health Investments Corp.
- SEC Form DEF 14A filed by Clover Health Investments Corp.
- SEC Form 4 filed by Priest Brady Patrick
- SEC Form 4 filed by Priest Brady Patrick
- SEC Form 4 filed by Soares Karen
- SEC Form 4 filed by Toy Andrew
- SEC Form 4 filed by Thornton Joseph Clay
- SEC Form 4 filed by Reynoso Jamie L.
- SEC Form 4 filed by Wai Conrad
- SEC Form 3 filed by new insider Oldakowski Joseph Frank
Latest DGX
- Quest Diagnostics Incorporated filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- SEC Form FWP filed by Quest Diagnostics Incorporated
- Quest Diagnostics Prices $500 Million of Senior Notes
- Executive Vice President & CFO Samad Sam was granted 108 shares, increasing direct ownership by 0.32% to 33,376 units (SEC Form 4)
- SVP for Diagnostic Services Plewman Patrick increased direct ownership by 0.32% to 15,247 units (SEC Form 4)
- Director Gregg Vicky B was granted 68 shares, increasing direct ownership by 0.40% to 17,172 units (SEC Form 4)
- Director Carter Robert B increased direct ownership by 0.26% to 2,711 units (SEC Form 4)
- Director Lassiter Wright Iii increased direct ownership by 0.07% to 9,063 units (SEC Form 4)
- SVP, Clinical Solutions Kuppusamy Karthik increased direct ownership by 0.29% to 13,490 units (SEC Form 4)
- SVP & Chief Commercial Officer Delaney Mark E increased direct ownership by 0.31% to 11,901 units (SEC Form 4)